GeneQuine Biotherapeutics Competitors and Similar CompaniesClear all
GeneQuine Biotherapeutics's competitors and similar companies include Synchronicity Pharma, IntraBio, Ultragenyx and Hubro Therapeutics.
 GeneQuine Biotherapeutics GeneQuine Biotherapeutics is a company developing gene therapy for the treatment of osteoarthritis. |  Synchronicity Pharma Synchronicity Pharma is a company that develops therapeutics focused on modulating circadian clock genes. |  IntraBio IntraBio is a biopharmaceutical company that develops therapies for genetic and neurodegenerative diseases. |  Hubro Therapeutics Hubro Therapeutics is a company that develops proprietary neo-peptide technology platforms and immunotherapies for the treatment of cancer. | ||
Founding Date | Founding Date 2012 | Founding Date N/A | Founding Date 2015 | Founding Date 2010 | Founding Date 2018 |
Type | Type Private | Type Private | Type Private | Type Public | Type Subsidiary |
Tags | |||||
Locations | Locations Hamburg, DE HQ | Locations HQ | Locations Begbroke, GB HQ | Locations Oslo, NO HQ | |
Employees | Employees 195% decrease | Employees 3 | Employees 4 | Employees 1,2763% decrease | Employees 3 |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $673m (FY, 2025) | Revenue (est.) kr53.6k (FY, 2021) |
Net income | Net income N/A | Net income N/A | Net income N/A | Net income ($575m) (FY, 2025) | Net income (kr7.5m) (FY, 2021) |
Funding | |||||
Latest funding round | Latest funding round $ 11m (over 5 years ago) | Latest funding round N/A | Latest funding round $ 4.9m (almost 8 years ago) | Latest funding round N/A | Latest funding round N/A |
Total funding raised | Total funding raised $ 11m | Total funding raised N/A | Total funding raised $ 4.9m | Total funding raised $ 200.1m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Synchronicity Pharma
HQ
Employees
3
Synchronicity Pharma is a company that develops therapeutics focused on modulating circadian clock genes.
View companyIntraBio
HQ
Begbroke, GB
Employees
4
IntraBio is a biopharmaceutical company that develops therapies for genetic and neurodegenerative diseases.
View company
Ultragenyx
HQ
Novato, US
Employees
1,276↓ 3% decrease
Ultragenyx Pharmaceutical is a company that develops therapies for rare genetic diseases.
View companyHubro Therapeutics
HQ
Oslo, NO
Hubro Therapeutics is a company that develops proprietary neo-peptide technology platforms and immunotherapies for the treatment of cancer.
View company